ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

NCT02100007 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

46

Enrollment

INDUSTRY

Sponsor class

Stopped lack of efficacy

Conditions

Solid Tumors

Interventions

DRUG: ME-344
DRUG: Topotecan

Sponsor

MEI Pharma, Inc.

Collaborators

[object Object]